Results 1 to 10 of about 58,843 (270)

Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review

open access: yesEurasian Journal of Medicine
Cerebrovascular events are linked to ankylosing spondylitis. Accelerated atherosclerosis and endothelial dysfunction against a backdrop of inflammation have been widely blamed for the increased cerebrovascular risk in ankylosing spondylitis.
Mohammad Mahdi Heidari   +5 more
doaj   +2 more sources

Spine Fractures of Patients with Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis: Fracture Severity and Injury-Related Mortality at a Level I Trauma Center [PDF]

open access: yesAsian Spine Journal, 2023
Study Design Retrospective review of prospectively collected cohort. Purpose To identify differences in treatment and mortality of spine fractures in patients with ankylosing conditions of the spine. Overview of Literature Ankylosing spondylitis (AS) and
Stephen Ryan Chen   +9 more
doaj   +1 more source

Primary Biliary Cholangitis with Ankylosing Spondylitis

open access: yesThe Korean Journal of Gastroenterology, 2022
Primary biliary cholangitis is a chronic inflammatory autoimmune liver disease that is characterized by a positive antimitochondrial antibodies test and progressive destruction of the small intrahepatic bile duct.
Young Mi Hong, Ki Tae Yoon, Mong Cho
doaj   +1 more source

Effect of Therapeutic Exercises Intervention on the Functional Status for Patients with Ankylosing Spondylitis [PDF]

open access: yesTanta Scientific Nursing Journal, 2023
Background: Regular exercises are of importance in the successful long-term management of Ankylosing Spondylitis. The study aimed to evaluate the effect of a specific exercise program on spinal and joints stiffness for patients with Ankylosing ...
Manar Mady   +3 more
doaj   +1 more source

A case of ankylosing spondylitis presenting with fever of unknown origin diagnosed as aortitis: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Clinicians should be aware of rare manifestations of AS, while considering a low threshold for screening vascular involvement in an axial SpA/nrxSpA/AS presenting with unexplained fevers and significant constitutional symptoms and ...
Mahsa Mehdipour Dalivand   +6 more
doaj   +1 more source

Biomarkers of response to therapy in Ankylosing Spondylitis [PDF]

open access: yes, 2013
Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine which leads to progressive spinal fusion and deformity. With improvements in MRI, this condition is now being recognized earlier.
Pathan, Ejaz Mohammed Ishaq
core   +1 more source

Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis

open access: yesСовременная ревматология, 2011
The paper describes the pathomorphological aspects of ankylosing spondylitis (AS) and the value of nonsteroidal anti-inflammatory drugs in its therapy. Clinical trials demonstrate the high efficacy of aceclofenac (aertal) in AS.
A A Godzenko
doaj   +1 more source

Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis

open access: yesEgyptian Rheumatology and Rehabilitation, 2021
Background Ankylosing spondylitis (AS) is an autoimmune multisystemic disease that attacks the spine, sacroiliacs, and often causes asymmetrical peripheral oligoarthritis. It results from the interaction between the genetic factors mainly Human Leukocyte
Hanan M. Farouk   +2 more
doaj   +1 more source

Total hip arthroplasty in patients with ankylosing spondylitis: challenges and midterm results [PDF]

open access: yesThe Egyptian Orthopaedic Journal
PurposeTo assess the effectiveness of total hip arthroplasty (THA) in patients with ankylosing spondylitis (AS).IntroductionThe prevalence of hip disease in AS ranges from 19 to 36%, with 90% of patients affected bilaterally.
Ahmed S. Eid   +2 more
doaj   +1 more source

Persistent clinical efficacy and safety of anti-tumour necrosis factor \textgreeka therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response [PDF]

open access: yes, 2008
Background: There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS).
Baraliakos, X.   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy